20 Jan 2010 Fully Human Monoclonal Anti-TNF-alpha Antibody HUMIRA Receives Approval as Japan's First Biological Agent for Psoriasis
19 Jan 2010 MorphoSys Enrolls First Patient in Phase 1b/2a Clinical Trial for MOR103 Program in Rheumatoid Arthritis
19 Jan 2010 Biotie reports positive top-line data from clinical study with VAP-1 antibody in rheumatoid arthritis patients - BTT-1023 is well tolerated and shows signals of therapeutic activity
19 Jan 2010 Enrollment Open for Clinical Trial of Cytolin, a Novel Immune Therapy from CytoDyn for Treating Early HIV Infection
19 Jan 2010 Perseid Achieves Preclinical Milestone Under Collaboration with Astellas for CTLA-4 Program
14 Jan 2010 STELARA Shows Greater Efficacy than Etanercept for Treatment Of Moderate-To-Severe Plaque Psoriasis
14 Jan 2010 Kenta Biotech Announces Collaboration with Rentschler Biotechnologie for Antibody Development Against Hospital-Acquired Infections
11 Jan 2010 FDA Approves ACTEMRA® (tocilizumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
11 Jan 2010 Apogenix Initiates Clinical Phase II Study with its Lead Compound APG101 in Glioblastoma
11 Jan 2010 Trubion Pharmaceuticals, Inc. Announces Initiation of a Phase 2 Study of SBI-087 for the Treatment of Rheumatoid Arthritis (RA)
11 Jan 2010 Symphogen Publishes Pre-Clinical Data in Cancer Research Demonstrating Superior Efficacy of Anti-EGFR Monoclonal Antibody Combination Sym004
11 Jan 2010 AnaptysBio Announces Agreement with Roche to Develop Novel Antibodies
11 Jan 2010 Facet Biotech Announces Enrollment of First Patient in Phase 2 Study of Elotuzumab in Patients With Relapsed Multiple Myeloma
11 Jan 2010 Sorrento Therapeutics Announces Antibody Discovery and Development Alliance for the Prevention and Treatment of MRSA Infections
11 Jan 2010 Sanofi Pasteur Partners with KaloBios on Novel Biologic for the Prevention and Treatment of Pseudomonas aeruginosa Infections
07 Jan 2010 Pfizer and Debiopharm collaborate to co-develop investigational compound tremelimumab (CP-675,206) in advanced melanoma
07 Jan 2010 Prolias Announces Strategic Technology Acquisition for Human Therapeutic Antibodies
07 Jan 2010 Tolerx Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab
06 Jan 2010 InNexus Biotechnology Develops New Psoriasis Product Based on Its Skin Permeating Antibody Technology
04 Jan 2010 First Patient treated in BioInvent's Phase I Study of the Drug Candidate BI-505 to Treat Multiple Myeloma
04 Jan 2010 NeoPharm Announces IND Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
29 Dec 2009 Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility
24 Dec 2009 MedImmune Replies to FDA Complete Response Letter on Motavizumab
22 Dec 2009 PDL BioPharma Announces New Licensing Agreement With Eli Lilly

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up